Edwards Larry Todd 4
4 · Arcutis Biotherapeutics, Inc. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Edwards Larry Todd
See Remarks
Transactions
- Award
Common Stock
2023-09-27+60,000→ 60,000 total - Award
Stock Option (right to buy)
2023-09-27+240,000→ 240,000 totalExercise: $5.58Exp: 2033-09-27→ Common Stock (240,000 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units ("RSUs") will vest as to 25% of the RSUs on each annual anniversary of October 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]The option will vest and become exercisable as to 25% of the shares subject to the option on October 1, 2024, and the remaining options will vest at 2.0833% subject to the options on each monthly anniversary thereafter, subject to Reporting Person's continued service through the applicable vesting date.